medical diagnosis

SpotLab

Transform clinical data into biomedical insights and accelerate disease screening with AI-powered diagnostic tools designed for global health equity.

Paid only

Price not published

SpotLab screenshot

About SpotLab

SpotLab is an AI model factory and technology platform specifically designed for the fields of diagnostics and biopharmaceutical research. Originally founded as a spin-off from the Universidad Politécnica de Madrid, the organization focuses on bridging the gap between artificial intelligence and biomedicine. Its primary goal is to provide accessible, high-quality healthcare solutions by automating the identification and quantification of digital biomarkers. The platform facilitates the transition from raw clinical data to actionable biomedical insights, which is crucial for advancing personalized medicine and improving patient outcomes in diverse environments. The platform operates through two main solution streams: Discover and Diagnostic Aid. In the Discover phase, SpotLab helps researchers identify digital biomarkers of disease progression and treatment response, which is particularly valuable for biopharma companies during clinical trials. For diagnostic assistance, the company offers specialized AI products like MedulAI and ParasitAI. These tools assist in the screening and diagnosis of various conditions, ranging from blood cancers to neglected tropical diseases like helminth infections. By using AI to analyze stool samples or blood films, the tool reduces inter-observer variability and helps harmonize diagnostic standards across different clinical sites. SpotLab is ideally suited for clinical researchers, biopharmaceutical companies, and healthcare providers operating in both well-resourced and resource-limited settings. Its technology is designed to be used globally, evidenced by its collaborations with organizations like the Kenya Medical Research Institute and the Bill & Melinda Gates Foundation. This makes it a versatile tool for labs looking to increase efficiency and accessibility in disease screening. Unlike many generic AI platforms, SpotLab’s multidisciplinary team combines expertise in both AI and clinical science, ensuring that their models are grounded in real-world biomedical contexts. What distinguishes SpotLab is its commitment to health equity and its model factory approach. Rather than offering a one-size-fits-all solution, they customize AI models to address specific clinical challenges. The platform is built to handle complex tasks like the identification of helminth eggs in stool samples with high precision, which requires specialized training data often ignored by mainstream medical AI. By focusing on both high-end biopharma research and neglected tropical diseases, SpotLab demonstrates a unique ability to scale advanced technology for global social impact while maintaining rigorous scientific standards.

SpotLab pros & cons

Pros

  • Specialized models for neglected diseases like helminth infections often overlooked by competitors.
  • Strong academic and institutional backing from Universidad Politécnica de Madrid and the European Commission.
  • Multidisciplinary team that bridges the gap between AI engineering and clinical practice.
  • Proven track record with major global partners like the Gates Foundation and NVIDIA.
  • Reduces diagnostic variability across different clinical sites and observers.

Cons

  • Pricing information is not publicly available on the website, requiring direct contact for quotes.
  • The platform appears to be highly specialized, which may have a steep learning curve for non-clinical users.
  • Some products like MedulAI and ParasitAI may require specific hardware or integration workflows not detailed on the main page.

SpotLab use cases

  • Biopharma researchers can utilize the Discover tool to identify digital biomarkers in clinical trial data, accelerating the development of personalized treatments.
  • Clinical laboratory technicians can use ParasitAI to automate the identification of helminth eggs in stool samples, increasing screening throughput and accuracy.
  • Oncologists can leverage MedulAI as a diagnostic aid to assist in the screening of blood cancers, reducing the risk of human error and inter-observer variability.
  • Global health organizations can deploy SpotLab’s AI solutions in remote areas to provide diagnostic capabilities where specialist doctors are unavailable.

SpotLab features

  • digital biomarker identification
  • customized ai model development
  • collaborative research platform
  • neglected tropical disease detection
  • blood cancer diagnostic assistance
  • inter-observer variability reduction
  • clinical data transformation
  • automated disease screening

SpotLab pricing

Is SpotLab free? No, SpotLab doesn't offer a free plan.

Contact Sales

Price varies

  • Custom AI model development
  • Biomarker discovery
  • Diagnostic aid integration
  • MedulAI access
  • ParasitAI access
  • Clinical research support
  • Global deployment assistance

SpotLab FAQs

What kind of diseases can SpotLab's AI help diagnose?

SpotLab specializes in a wide range of conditions, including blood cancers through their MedulAI product and neglected tropical diseases via ParasitAI. They have specifically developed models for identifying helminth eggs like Ascaris lumbricoides and hookworms in stool samples.

Who can benefit from using the SpotLab platform?

The platform is designed for clinical researchers, biopharmaceutical companies, and healthcare providers. It is particularly useful for those looking to automate diagnostics, identify new biomarkers, or improve healthcare accessibility in resource-limited settings.

Is SpotLab a research-only tool or can it be used in clinical practice?

While SpotLab is used heavily in biopharma research for biomarker discovery, its products like MedulAI and ParasitAI are specifically designed as diagnostic aids to assist in clinical screening and diagnosis.

How does SpotLab ensure the accuracy of its AI models?

SpotLab employs a multidisciplinary team of over 20 scientists and engineers to develop their models. Their technology is validated through global collaborations and research with institutions like the Kenya Medical Research Institute.

Does SpotLab offer customized AI models for specific research needs?

Yes, through their Discover solution, SpotLab transforms clinical data into new biomedical insights by creating customized AI models tailored to identify specific digital biomarkers of disease.

Ratings & reviews

No reviews yet. Be the first to share how SpotLab worked for you.